3Wada H,Yokomise H,Tanaka F,et al.Surgical treatment of small cell carcinoma of the lung:advantage of preoperative chemotherapy.Lung Cancer,1995,13:45-46.
4Sorensen HR,Lund C,Alstrup P.Survival in small cell lung carcinoma after surgery.Thorax,1986,41:479-482.
5Shah SS,Thompson J,Goldstraw P.Results of operation without adjacent therapy in the treatment of small cell lung cancer.Ann Thorac Surg,1992,54:498-501.
6Inoue M,Miyoshi S,Yasumitsu T,et al.Surgical results for small cell lung cancer based on the new TNM staging system.Thoracic Surgery Study Group of Osaka University,Osaka,Japan.Ann Thorac Surg,2000,70:1615-1619.
5Takada M, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol, 2002, 20:3054-3060.
6Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with eisplatin and etoposide. N Engl J Med, 1999, 340:265-271.
7Tsuchiya R, Suzuki K, Ichinose Y, et al. Phase Ⅱ trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage Ⅰ-Ⅲa small cell lung cancer: the Japan Clinical Ontology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg, 2005, 129:977-983.
8de Antonio DG, Alfageme F, Gamez P, et al. Results of surgery in small cell carcinoma of the lung. Lung Cancer, 2006, 52:299- 304.
9Bremnes RM, Sundstrom S, Aasebo U, et al. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer, 2003, 39:303-313.
10Singh S, Parulekar W, Murray N, et al. Influence of sex on toxicity and treatment outcome in small-cell lung cancer. J Clin Oncol, 2005, 23:850-856.
